Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brenda Weigel

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
JCO Precision Oncology|October 30, 2025
Germline Cancer Predisposition Results From the National Cancer Institute-Children's Oncology Group Pediatric MATCH TrialSarah Scollon, Sharon E Plon, Steven Joffe, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2022
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Carl Allen, Jason Fangusaro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2014
Toward a drug development path that targets metastatic progression in osteosarcomaChand Khanna, Timothy M Fan, Richard Gorlick, et al.
European Journal of Cancer (Oxford, England : 1990)|July 18, 2025
Paediatric strategy forum for medicinal product development of cyclin-dependent kinase inhibitors in children and adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug AdministrationAndrew Dj Pearson, Susan Chi, Theodore W Laetscht, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2024
Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancerAndrew Dj Pearson, Steven G DuBois, Margaret E Macy, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2023
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew D J Pearson, Sara Federico, Susanne A Gatz, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug AdministrationAndrew D J Pearson, Elly Barry, Yael P Mossé, et al.
The Lancet. Oncology|April 3, 2025
New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysisAndrew D J Pearson, Claudia Rossig, Crystal L Mackall, et al.
European Journal of Cancer (Oxford, England : 1990)|January 28, 2020
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patientsAndrew D J Pearson, Claudia Rossig, Giovanni Lesa, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2022
Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Nathalie Gaspar, Katherine Janeway, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
JCO Precision Oncology|October 30, 2025
Germline Cancer Predisposition Results From the National Cancer Institute-Children's Oncology Group Pediatric MATCH TrialSarah Scollon, Sharon E Plon, Steven Joffe, et al.
European Journal of Cancer (Oxford, England : 1990)|November 6, 2022
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Carl Allen, Jason Fangusaro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2014
Toward a drug development path that targets metastatic progression in osteosarcomaChand Khanna, Timothy M Fan, Richard Gorlick, et al.
European Journal of Cancer (Oxford, England : 1990)|July 18, 2025
Paediatric strategy forum for medicinal product development of cyclin-dependent kinase inhibitors in children and adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug AdministrationAndrew Dj Pearson, Susan Chi, Theodore W Laetscht, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2024
Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancerAndrew Dj Pearson, Steven G DuBois, Margaret E Macy, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2023
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew D J Pearson, Sara Federico, Susanne A Gatz, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug AdministrationAndrew D J Pearson, Elly Barry, Yael P Mossé, et al.
The Lancet. Oncology|April 3, 2025
New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysisAndrew D J Pearson, Claudia Rossig, Crystal L Mackall, et al.
European Journal of Cancer (Oxford, England : 1990)|January 28, 2020
ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patientsAndrew D J Pearson, Claudia Rossig, Giovanni Lesa, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2022
Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Nathalie Gaspar, Katherine Janeway, et al.
Pageof 5